This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Krishna Kannan, PhD
Senior Director, Product Development at Telesis Bio


Dr. Krishna Kannan is the Senior Director of Product Development at Telesis Bio. He received his PhD from the University of Illinois at Chicago. He is a long-time associate of Dr. Dan Gibson– the creator of the Gibson assembly® method and has worked closely with other Synthetic Biology pioneers at the J Craig Venture Institute and Viridos (formerly Synthetic Genomics), contributing to the development of the first synthetic cell with a minimal genome and the digital-to-biological converter. Dr. Kannan is widely published in leading peer-reviewed publications such as Cell, Science and Nature Biotechnology. Most recently he has been instrumental in synthetic biology workflow innovations at Telesis Bio including the first de novo full-length construction of the SARS-CoV-2 genome and the novel digital sequence-to-mRNA synthesis automation workflow. Dr. Kannan’s team has also been critically involved in the introduction of the next-generation of Telesis Bio’s automated synthetic biology workstation, the BioXp 9600.

Agenda Sessions

  • The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking through Critical Synthesis Bottlenecks